Patients, fearing arrest, wait longer for care or skip it. Doctors and health system leaders say the disruption poses a risk to public health.
As Utah pilots the use of AI for renewing drug prescriptions, experts ask if the technology should be regulated as a medical device.
BPC-157 is touted as a healing peptide, but nearly all data comes from animal studies and a single research group, raising safety and regulatory concerns.
Health secretary RFK Jr. has suggested officials could seek to end importation of non-human primates for scientific study.
American Society of Plastic Surgeons endorses ‘individual decision-making' while recommending gender-affirming surgeries be delayed until 19
The company said its drug, which it picked up through buying Metsera, could help patients continue losing weight with less frequent dosing.
The federal health department is rapidly acquiring and deploying AI tools, according to recently released data from the agency’s technology office.
The Danish pharma giant said it faults expiring patents in some international markets and a pricing deal with White House.
